Nu Skin Enterprises Files 2024 Proxy Statement

TL;DR

NUS proxy filed: vote on directors & auditors for 2024 meeting.

AI Summary

Nu Skin Enterprises, Inc. filed its definitive proxy statement on April 12, 2024, for its annual meeting on June 5, 2024. The filing details executive compensation, board nominations, and other corporate governance matters for the fiscal year ending December 31, 2023. Key proposals include the election of directors and the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company leadership and financial oversight, impacting the company's strategic direction and governance.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) that provides information to shareholders and does not inherently introduce new risks.

Key Numbers

• 20240605 — Annual Meeting Date (Shareholders will vote on proposals at this meeting.)
• 20240412 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
• 2023 — Fiscal Year End (The proxy statement covers corporate matters for this fiscal year.)

Key Players & Entities

• NU SKIN ENTERPRISES, INC. (company) — Registrant
• GREGORY BELLISTON (person) — Contact Person for Mail and Business Address
• PricewaterhouseCoopers LLP (company) — Proposed Independent Registered Public Accounting Firm

FAQ

From the Filing

0001140361-24-019638.txt : 20240412 0001140361-24-019638.hdr.sgml : 20240412 20240412164919 ACCESSION NUMBER: 0001140361-24-019638 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 33 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 24842104 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 DEF 14A 1 ny20025256x1_def14a.htm 2024 PROXY STATEMENT   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A INFORMATION   Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.      )       Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐   Preliminary Proxy Statement ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒   Definitive Proxy Statement ☐   Definitive Additional Materials ☐   Soliciting Material Pursuant to §240.14a-12           NU SKIN ENTERPRISES, INC.   (Name of Registrant as Specified In Its Charter)   (Name of Person(s) Filing Proxy Statement, if other than the Registrant)   Payment of Filing Fee (Check all boxes that apply): ☒   No fee required ☐   Fee paid previously with preliminary materials ☐   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11             NOTICE OF ANNUAL MEETING OF STOCKHOLDERS OF NU SKIN ENTERPRISES, INC.   NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the “Annual Meeting”) of Nu Skin Enterprises, Inc., a Delaware corporation, will be held at 11:00 a.m., Mountain Daylight Time, on June 5, 2024, at our corporate offices, 75 West Center Street, Provo, Utah 84601.   At the Annual Meeting, you will be asked to consider and vote on the following matters, which are more fully described in the proxy statement:   1. To elect the eight directors named in the attached proxy statement;   2. To hold an advisory vote to approve our executive compensation;   3. To approve our 2024 Omnibus Incentive Plan;   4. To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024; and   5. To transact such other business as may properly come before the Annual Meeting.   The Board of Directors has fixed the close of business on April 8, 2024 as the record date for determining the stockholders entitled to receive notice of and to vote at the Annual Meeting or any adjournment or postponement thereof.   You are cordially invited to attend the Annual Meeting in person. However, to ensure your representation at the Annual Meeting, please mark, sign, date and return the accompanying proxy card as promptly as possible in the enclosed postage-paid envelope, or use the internet or telephone methods that are described on the proxy card. If you attend the Annual Meeting, you may, if you wish, withdraw your proxy and vote at the meeting.   Important Not